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Abstract
Background: In the human lung, epithelial progenitor cells in the airways give rise to the differentiated
pseudostratified airway epithelium. In mice, emerging evidence confers a progenitor function to cytokeratin 5
(KRT5+) or cytokeratin 14 (KRT14+)-positive basal cells of the airway epithelium. Little is known, however, about the
distribution of progenitor subpopulations in the human lung, particularly about aberrant epithelial differentiation in
lung disease, such as idiopathic pulmonary fibrosis (IPF).
Methods: Here, we used multi-color immunofluorescence analysis to detect and quantify the distribution of airway
epithelial progenitor subpopulations in human lungs obtained from healthy donors or IPF patients.
Results: In lungs from both, healthy donors and IPF patients, we detected KRT5+KRT14-, KRT5-KRT14+ and KRT5
+KRT14+ populations in the proximal airways. KRT14+ cells, however, were absent in the distal airways of healthy
lungs. In IPF, we detected a dramatic increase in the amount of KRT5+ cells and the emergence of a frequent KRT5
+KRT14+ epithelial population, in particular in distal airways and alveolar regions. While the KRT14- progenitor
population exhibited signs of proper epithelial differentiation, as evidenced by co-staining with pro-SPC, aquaporin
5, CC10, or MUC5B, the KRT14+ cell population did not co-stain with bronchial/alveolar differentiation markers in
IPF.
Conclusions: We provide, for the first time, a quantitative profile of the distribution of epithelial progenitor
populations in human lungs. We show compelling evidence for dysregulation and aberrant differentiation of these
populations in IPF.
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Background
Lung function, barrier integrity, and epithelial homeosta-
sis are maintained, in large parts, by its inner lining,
which is constituted by lung epithelial cells. Different
types of lung epithelial cells have been identified and
characterized in the past, including ciliated, goblet, or
basal cells in proximal airways, and ciliated, club (Clara),
neuroendocrine, or basal cells in distal airways. The
pseudostratified airway epithelial layer continues into a
flat epithelial layer composed of alveolar type 1 (AT1) or
type 2 (AT2) cells in the alveolar regions. Lung injury in-
duced by injurious agents (e.g. cigarette smoke, particu-
late matter, viruses) primarily affects the integrity of this
epithelial compartment, either by inducing barrier dys-
function or epithelial progenitor cell perturbation [1–4].
Recently, lung epithelial progenitor cells have attracted
significant interest, as they serve as stem cells for differ-
entiated lung epithelial cell types, such as secretory, cili-
ated, or AT1 cells in mice [3]. Basal cells are relatively
undifferentiated epithelial cells, which are located at-
tached to the basal lamina of the stratified and pseudos-
tratified airway epithelium [5]. Basal cells participate in
anchoring of the airway epithelium to the basement
membrane and thus separate the underlying stroma
from the epithelial tubes. Airway basal cells also
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maintain the homeostasis of the normal epithelial layer
by giving rise to the differentiated airway epithelial cells
during postnatal growth and in the adult under steady
state, as previously shown by us and others using a var-
iety of in vivo and in vitro assays [6–8].
Airway basal cell dysfunction contributes to a num-
ber of pathologies, as disruption in the balance be-
tween basal cell proliferation and differentiation leads
to epithelial hyperplasia/hypoplasia [5] or abnormal
differentiation patterns [4, 9], e.g. in lung cancer. Hy-
perplastic basal cell lesions are also observed in
chronic obstructive pulmonary disease (COPD) [5, 10]
and cystic fibrosis (CF) [11], whereas the epithelial in-
jury and loss in bronchiolitis obliterans syndrome
(BOS) may indicate stem cell exhaustion or a loss in
epithelial progenitor populations [5].
In mice, recent studies using a number of reporter
and fate-mapped mouse strains have demonstrated
that lung basal cells contribute to regeneration of
the lung in response to injury, based on their cap-
acity to proliferate and differentiate into mature cell
types [12, 13]. Evidence of the regenerative capacity
of basal cells in human results from the observation
that basal cells isolated from different regions of the
human lung proliferate and differentiate to mature
ciliated, goblet, or club (Clara) cells in air-liquid
interface (ALI) cultures or bronchosphere assays
ex vivo [14]. In vivo, injury/repair models have dem-
onstrated that disruption of the basal cell layer is as-
sociated with an uncontrolled proliferation of the
underlying stroma, resulting in an accumulation of
fibroblasts and immune cells that subsequently oblit-
erate the airways [15].
Emerging evidence shows that basal cells are com-
posed of multiple heterogeneous subpopulations, under
physiological as well as pathological conditions. As an
example, mouse tracheal basal cells characteristically ex-
press cytokeratin 5 (KRT5), while only a limited subset
expresses cytokeratin 14 (KRT14). Interestingly, KRT14
is upregulated in mouse lung basal cells in response to
naphtalene-injury [16]. As such, ongoing evidence high-
lights a role for KRT5+KRT14+ basal cells in post-injury
regeneration of the mouse lung [6, 12–14].
Details about definitive basal cell subpopulations, how-
ever, remain to be elucidated, in particular in the human
lung. In this context, basal cell subsets expressing dis-
tinct keratin (KRT) isoforms have been described [17]
and recent evidence suggests alterations in KRT abun-
dance and expression in lung disease with features of
diffuse alveolar damage [18, 19]. Increased KRT5 and
KRT14 expression has also been reported in the alveolar
regions in idiopathic pulmonary fibrosis (IPF) [19]. Yet,
the distinct quantitative and spatial abundance of KRT5+
and KRT14+ cells to IPF is unknown.
To this end, we sought to investigate and quantify the
distribution of KRT5+ and KRT14+ cell populations in
human lungs, obtained from healthy donors or IPF pa-
tients. We provide here, for the first time, a quantitative
analysis of the distribution of KRT5+ and KRT14+ single-
and double-positive cell populations in the healthy hu-
man lung. Importantly, we describe dramatic changes in
the distribution and morphology of these cells in IPF. Fi-
nally, we seek to characterize their differentiation poten-
tial by fluorescent co-staining of these populations with
well-accepted epithelial differentiation markers, such as
acetylated tubulin, Mucin 5B, or Clara Cell 10 kDa Pro-
tein (CC10) in IPF.
Methods
Human lung material
Resected human lung tissue and explant material was
obtained from the bioarchive at the Comprehensive
Pneumology Center (CPC). Biopsies were obtained from
6 healthy donors and 5 IPF patients (UIP pattern, mean
age: 57,6 ± 3,25, 3 males, 2 females). All participants gave
written informed consent and the study was approved
by the local ethics committee of Ludwig-Maximilians
University of Munich, Germany (333-10). For staining,
human lung tissue was fixed in 4 % PFA prior to paraffin
embedding. The 4 μm-sections were prepared with a
microtome (Hyrax M 55, Zeiss) and mounted on Super-
frost slides.
Isolation of primary human bronchial epithelial cells
Basal cells were isolated from bronchial tissue
(>2 mm) resected from the peripheral tumor region
of otherwise normal healthy lungs. For this, the tissue
was longitudinally cut, washed 3 times in MEM, sup-
plemented with L-glutamine (2 mM) and pen/strep
(100 U/ml, 100 μg/ml), and digested with Pronase E
(1 mg/mL) in MEM with L-glutamine and pen/strep
for 20 h at 4 °C under constant agitation. The next
day, the epithelium was scraped off using a scalpel,
cells further separated with an 18G and 25G needle
and collected by centrifugation at 300 × g for 5 min.
Isolated cells were suspended in BEGM medium
(Lonza; Wokingham, UK), seeded onto rat-tail colla-
gen type I (Sigma-Aldrich; St. Louis, MO) coated
dishes, and incubated at 37 °C in a humidified incu-
bator with 95 % air and 5 % CO2. Cells which have
reached 80 % confluence were detached using the
Clonetics™ ReagentPack™ for subculturing (Lonza) and
1×104 cells/cm2 were seeded onto collagen type I
coated coverslips. Two days later, cells were washed
with HBSS, fixed with 4 % PFA for 15 min and
stored in HBSS at 4 °C until analysis.
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Dual immunofluorescence analysis
All tissue stainings were performed on 4 μm-sections
of lung tissue. Sections were cleared of paraffin by in-
cubation at 60 °C (1 h) and subsequent xylene
washes. Sections were then rehydrated using 100 %
ethanol, followed by distilled water. Antigen retrieval
was performed in 0.01 M Citric Acid (pH 6.0) in a
decloacking chamber for 30 s at 125 °C. After wash-
ing in distilled water, slides were blocked for 1 h at
room temperature using 5 % BSA in PBS (blocking
solution, BS). Primary antibodies were diluted in BS
and applied to sections overnight, at 4 °C. The pri-
mary antibodies and their dilutions used to identify
the cell types indicated in Table 1 were as follows:
α-Cytokeratin 5 (both 1:250, clones EP1601Y or 2C2,
respectively ab52635 or ab128190, Abcam), α-Cytokeratin
14 (1:200, clone LL002, ab7800, Abcam), α-p63 (both
1:25, clone 4A4, sc-8431, Santa-Cruz; or clone EPR5701,
ab124762, Abcam), α-aquaporin 5 (1:100, clone C-19,
sc-9891, Santa-Cruz), α-Pro-Surfactant Protein C (1:100,
polyclonal, AB3786, EMD Millipore), anti-CC10 (1:100,
clone H-75, sc-365992, Santa-Cruz), α-acetylated tubulin
(1:250, clone AcetylK40, ab125356, Abcam), α-Mucin
5B (1:100, clone H-300, sc-20119, Santa-Cruz). Devel-
opmental pathway markers were used as follows:
α-Sonic Hedgehog (1:100, clone 171018, ab50515,
Abcam), α-GLI1 (1:50, polyclonal, ab49314, Abcam),
α-SOX9 (1:50, polyclonal, AF3075, R&D Systems),
α-HES1 (1:50, clone H-140, sc-25392, Santa-Cruz).
Alexa488 (green) and Alexa586 (red)-labeled second-
ary antibodies (Life Technologies) were used at a
1:250 dilution in BS for 30 min. Nuclei were counter-
stained with DAPI and the slides mounted in fluores-
cent mounting medium (Dako, Hamburg, Germany).
For stainings of isolated primary human bronchial
epithelial cells, cells on coverslips were permeabilized
with DPBS/0.1 % Triton X-100 for 5 min and blocked
with BS for 1 h at room temperature. Staining for
Cytokeratin 5 and 14 was performed as described
above.
Image acquisition and analysis
All tissue images were acquired using the confocal
LSM710 Microscope (Carl Zeiss; Oberkochen,
Germany), coupled to the Zen2009 software, and
examined by three different observers. The quantifica-
tion of p63+, KRT5+ and KRT14+ cells was performed
by counting cells in which the cytoplasm (KRT5,
KRT14) or the nucleus (p63) exhibited a positive sig-
nal. The numbers of the indicated cells were normal-
ized to the length of the corresponding region of the
basement membrane, in case of conducting or distal
airways, or expressed as cell/mm2 of analyzed tissue.
Images of primary human bronchial epithelial cells
were obtained using the Axiovert II (Carl Zeiss) and
processed using the AxioVision 4.9 software (Carl
Zeiss).
Results
Identification and quantification of basal cell populations
in the conducting healthy airways
Human healthy airways were classified into conducting
and distal airways, according to the presence (conduct-
ing) or absence (distal) of cartilage and submucosal
glands in the vicinity, as previously described [5, 20].
Prominent staining for KRT5 was observed all along
the basement membrane of the conducting airway
epithelium (Fig. 1a). All p63+ basal cells/mm base-
ment membrane were KRT5+, while 14 % of all basal
cells were KRT5+p63- (Fig. 3). This fraction localized
luminal to the basal KRT5+p63+ population in the
stratified bronchial epithelium (Fig. 2a, left panel). A
costaining for KRT5 and KRT14 revealed the exist-
ence of a KRT5+KRT14+ subpopulation that was re-
stricted to the basal layer of the healthy conducting
airways (Figs. 1a and 2a, right panel). This population
was heterogeneously distributed, as some regions of
the conducting airways were densely populated with
KRT5+KRT14+ basal cells, while other regions had
few KRT14+ cells (Fig. 1a).
All KRT14+ cells along the basement membrane
were positive for p63 (Fig. 2a, left panel and Fig. 3).
KRT5+KRT14+ cells represented 40 % of all KRT5+
cells, suggesting that the remaining KRT5+ cells were
KRT5+KRT14-p63+ or KRT5+KRT14-p63- (Fig. 3). To
exclude staining bias of complex tissues, and to docu-
ment these populations by an independent analysis,
we isolated primary human bronchial epithelial basal
cells and subjected these to immunofluorescence
staining. We observed both KRT5+KRT14- and KRT5
+KRT14+ basal cell populations in primary isolated
human basal cells, in similar proportions that we
observed for lung tissue outlined above (Fig. 1c and
data not shown).
Table 1 Markers used in the study and commonly associated
cell types
Marker Cell type
Keratin 5 (KRT5) Basal cells (airways)
Keratin 14 (KRT14) Basal cells (regions of squamous metaplasia)
p63 Basal cells
Acetylated tubulin (acTUB) Ciliated cells
CC10 Clara cells
Mucin 5B (MUC5B) Goblet cells
ProSPC Alveolar type II cells
Aquaporin 5 (AQP5) Alveolar type I cells
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Only KRT5+KRT14-p63+ and KRT5-KRT14-p63+ basal cells
populate healthy human distal airways
In comparison to the large conducting airways, the pro-
portion of KRT5+p63+ basal cells decreased dramatically
(30 cells/mm basal membrane) in the distal airways of
the healthy lung (Fig. 3). Here, 40 % of p63+ cells did
not express KRT5, demonstrating the existence of a
KRT5-p63+ basal cell population. Importantly, we never
observed KRT14 staining in normal distal airways, sug-
gesting the complete absence of this population in the
healthy lung (Fig. 1b).
Distribution and nature of basal cell subpopulations in
conducting airways and the distal IPF lung
Similar to the healthy human lung, a KRT5+KRT14-p63+
(112 cells/mm basement membrane) and a rare KRT5
+KRT14-p63- population were present in conducting air-
ways of IPF patients (Fig. 4a). Similarly, 41 % of the total
KRT5+p63+ population expressed KRT14 (Fig. 6a). In
the distal IPF lung, however, the profile of KRT5 and
KRT14-expressing cells was dramatically altered com-
pared with healthy lungs (Fig. 4b). While KRT5+ cells
were only present in the basal layers of healthy distal
airways, this cell population was more widely distrib-
uted in the IPF interstitium. This KRT5+ progenitor
population was present in fibrotic areas, mostly as
pods (Fig. 6b), and dominant in bronchiolized areas
(85 % of all the KRT5+ cells found in the distal IPF
lung). KRT5+ cells exhibited a cuboidal or elongated
morphology in IPF airways, while they were pyramidal
in healthy distal airways (Fig. 4b). KRT5+ were fre-
quently organized into metaplastic epithelial-like
structures (Fig. 4b, two upper panels), single epithelial
layers with distinct cell morphology (Fig. 4b, lower
left panel), or grouped in clusters or pods (Fig. 4b,
lower right panel). While almost all KRT5+ cells were
p63+ (92 %), some also were p63-, mostly in inner























Fig. 1 Proximal-to-distal distribution of KRT5+ and KRT14+ basal cells subpopulations in the healthy human lung. a, b Sections from healthy
human lungs (6 donors) were co-stained for Keratin (KRT) 5 (green), KRT14 (red) and counterstained with DAPI (blue). Two representative pictures,
with corresponding high magnification panels, are shown for the conducting airways (a left and right panels) and the distal airways (b left and
right panels). Arrow: KRT5+ cell with characteristic luminal epithelial cell morphology. Full bars = 500 μm. Scattered bars = 100 μm. c Isolated
primary human bronchial epithelial cells (hBEC) were co-stained for KRT 5 (green), KRT14 (red) and counterstained with DAPI (blue). The panels
show: Keratin5-DAPI (left), Keratin14-DAPI (middle) and merged (right) images. Full bars = 500 μm. Scattered bars = 100 μm
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ongoing differentiation processes similar to the KRT5
+ luminal cells in the conducting airways.
In striking contrast to the findings observed in healthy
lungs, a KRT5+KRT14+ population emerged in the distal
IPF lung, and accounted for a significant part of the total
KRT5+ population (24 % in the bronchiolized areas, and
30 % in the fibrotic areas) (Fig. 6b). These cells were fre-
quently detected in areas of basal cell metaplasia and
mostly grouped together in clusters, suggesting clonal
expansion.
KRT5+ cells, but not KRT14+ cells, coexpress epithelial cell
differentiation markers in the distal IPF lung
In order to assess the differentiation potential of KRT5
+KRT14- and KRT5+KRT14+, costainings of KRT5+ or
KRT14+ cells with a variety of alveolar or bronchiolar
differentiation markers were performed (Fig. 7). Clusters
of KRT5+ cells in the distal IPF lung exhibited co-
expression of aquaporin (AQP) 5 or Pro-Surfactant Pro-
tein C (SPC), representing AT1 or AT2 markers, re-
spectively (Fig. 7a, b). While all KRT5+ cells exhibited
co-expression of such differentiation markers, KRT14+
cells, in striking contrast, did not co-express any of the
known differentiation markers. In addition, KRT14+ cells
did not even localize in proximity of AQP5+ or ProSPC+
cells. Thus, our results suggest the existence of a KRT5
+KRT14- population in the IPF distal lung, which poten-
tially exhibits differentiation capacity into a proper al-
veolar epithelial cell phenotype (AT1 or AT2 cells),
whereas KRT5+KRT14+ cell did not exhibit this
phenotype.
We also characterized the hyperplastic bronchiolar le-
sions in IPF. Layers composed of KRT5+ basal cells in
the distal IPF pods presented in close proximity of
AcTub+-ciliated cells (Fig. 7c, left panel) or CC10+-club
(Clara) cells (Fig. 7d, upper left panel). Interestingly, the
presence of KRT14+ cells within the basal layer was as-
sociated with an absence of differentiated ciliated or
Clara cells in the luminal layer, similar to our observa-
tion of AQP5 staining (Fig. 7c, upper right panel and
Fig. 7d, upper right panel). Importantly, CC10 was found















Fig. 2 Coexpression of p63 with KRT5 and KRT14 in the healthy human lung. Sections from healthy human lungs (6 donors) were co-stained either for
KRT5 (green) and p63 (red) (a left; b left), or KRT14 (red) and p63 (green) (a right; b right) and counterstained with DAPI (blue). One representative picture,
with the corresponding high magnification panel, is shown for each staining, for the conducting (a) and distal (b) healthy airways. Arrow: KRT5-p63+

















Fig. 3 Quantification of total basal cells and KRT5+ and KRT14+ basal
cell subpopulations in the healthy human lung. Cells were counted
according to their positivity for p63, KRT5 or KRT14 immunostaining in
conducting airways (1 donor, 2 samples, n = 7 assessed fields/sample)
and in distal airways (5 donors, 1-3 samples/donor, n = 34 assessed
bronchioles). Data are expressed as mean ± SEM. A 2-Way ANOVA with
Bonferroni post-test revealed a significant interaction according to the
type of airway (Conducting versus distal, p < 0.0001); all 6 quantified
populations were significantly different between conducting and distal
airways (***p < 0.001). Each dataset (conducting and distal) was then
compared separately with a One-Way ANOVA test: ***p < 0.001 versus
“Conducting KRT5+”, ###p < 0.001 versus “Distal KRT5+”
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lacked the morphology of differentiated Clara cells
(Fig. 7d). In some hyperplastic epithelial structures,
KRT5, but not KRT14, costained with Mucin (MUC) 5B
in luminal layers (Fig. 7e, left panel). KRT14+ cells, on
the other hand, were confined to the basal layer in which
secreted MUC5B filled bronchiolar structure (Fig. 7e,
right panel).
To further assess whether these basal cell progenitors
exhibited evidence of reactivation of developmental sig-
naling pathways in IPF, we co-stained KRT5 + -basal
cells with Sonic Hedgehog, GLI1, SOX9, or HES1
(Fig. 8). Sonic Hedgehog failed to costain in KRT5+ cells
(Fig. 8a), while its target transcription factor (GLI1) lo-
calized to the nucleus of most of the KRT5+ cells
(Fig. 8b). SOX9 and HES1 stained the nuclei of some
KRT5+ cells (Fig. 8c, d), indicating the presence of KRT5
+SOX9+, KRT5+SOX9-, KRT5+HES1+ and KRT5+HES1-
subpopulations amongst the IPF basal cell progenitors.
Discussion
We show, for the first time, a proximal-to-distal quanti-
fication of bronchial basal cell subtypes in the human
lung, characterized by various combinations of p63,
KRT5, and KRT14 expression. While several combina-
tions of KRT5+/-KRT14+/-p63+/- basal cells populate the
human airways in distinct locations, the total absence of
a KRT5+KRT14+p63+ population in the healthy distal
lung is remarkable. In IPF, the overall amount and distri-
bution of the KRT5+p63+ cells is dramatically modified,
and a frequent KRT5+KRT14+p63+ population emerges
in the distal IPF lung. While KRT14- cells co-expressed
alveolar and bronchial epithelial differentiation markers,
KRT14+ cells exhibit a metaplastic phenotype and failed
to costain with any of these markers. This strongly sug-
gests that the KRT5+KRT14+p63+ cell type identified in
the distal IPF lung is functionally different from the
KRT5+KRT14-p63+ cell population.
The decrease in basal cell numbers along the
proximal-distal axis reported herein is consistent with
the profile reported 27 years ago by Boers et al. [21]. In
modification to those observations, we used the well-
accepted basal cell marker p63 for cell quantification,
which gives a more precise estimation of total basal cell
numbers compared with morphological measures alone
[4]. We sought to characterize and quantify airway epi-





















Fig. 4 KRT5+ and KRT14+ basal cell subpopulations in the IPF lung. Sections from IPF human lungs (5 patients) were co-stained for KRT5 (green),
KRT14 (red) and counterstained with DAPI (blue). a Two representative pictures, with corresponding high magnification panels, are shown for the
conducting airways. b 4 representative pictures, with corresponding high magnification panels, illustrate the distribution patterns (metaplastic,
simple and pod-like) of KRT5+ and KRT14+ basal cell subpopulations in the distal IPF lung. Full bars = 500 μm. Scattered bars = 100 μm
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missing up-to-date, while quantitative investigations
have been performed for KRT5+KRT14- and KRT5
+KRT14+ populations in the mouse trachea [22]. Evi-
dence of the expression of KRT5, but not KRT14, by
human basal cells came from colony forming-basal
cells, isolated from the proximal or distal human lung
[14]. The expression of KRT14 in human basal cells
was observed in basal layers of bronchospheres
formed by basal cells from human lungs [6]. In
addition, early studies also described KRT14 expres-
sion in basal cells in conducting healthy human air-
ways, although without any evidence of KRT5
expression [17]. Thus, our study now provides evi-
dence that 1) KRT5+KRT14-p63+ and KRT5+KRT14
+p63+ populations coexist in similar proportions in
the conducting airways, 2) KRT5+KRT14+p63+ cells
are absent from distal human healthy lungs, 3) some
KRT5+ cells are p63-, which suggests a sequential loss
of basal cells markers during steady state cell renewal
in the conducting airways; and 4) a rare population of
KRT5-p63+ exists in the distal human lung, previously
observed also by Vaughan et al. [12]. This KRT5-p63+
population of the distal airways could either express
KRT17 [17] or KRT15, which is described as a
marker for all basal cells in the mouse trachea [22].
IPF is a progressive, irreversible, and fatal lung disease,
in which the lung epithelium is replaced by scarring tis-
sue rich in collagens and extracellular matrix, honey-
combing, and myofibroblast-rich regions. Available
therapeutic approaches slow down progression of the
disease, but regenerative medicine approaches would
represent a promising novel option for the treatment of
IPF [23]. As such, one potential option is to target basal
cells, endogenous lung epithelial cells likely to have re-
generative potential. While the accumulation of p63+
cells has been previously reported in IPF [24], distinct
subpopulations were undefined. Similarly, an accumula-
tion of KRT5+ cells [12], as well as KRT5+-KRT14+ cells
[20] has been observed, but neither quantified nor char-
acterized. Here, we show that, in striking contrast to
normal lungs, distal IPF lungs present 1) an increased
abundance of KRT5+ cells, 2) the emergence of a fre-
quent KRT5+KRT14+ subpopulation, 3) morphological
changes in these basal cells, and 4) the existence of char-
acteristic patterns of KRT5+KRT14- and KRT5+KRT14+


















Fig. 5 Coexpression of p63 with KRT5 and KRT14 in the IPF lung. a, b Sections from IPF human lungs (5 patients) were co-stained either for KRT5
(green) and p63 (red) (a left; b left), or KRT14 (red) and p63 (green) (a right; b right) and counterstained with DAPI (blue). One representative picture,
with the corresponding high magnification panel, is shown for each staining, for the conducting (a) and distal (b) healthy airways. c Characteristic
KRT5+ pod, stained for KRT5 (green) and p63 (red). Arrow: KRT5+p63- cell. Full bars = 500 μm. Scattered bars = 100 μm
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different progenitor subpopulations revealed a regional
heterogeneity in the distal IPF lung. While in healthy-
like non fibrotic, or in fibrotic areas, the basal cell pro-
genitors are rarely found, they are abundant in areas of
bronchiolization, suggesting the possibility of an ongoing
regenerative process in these specific regions.
Current knowledge in this field is limited by the lack
of an irreversible animal model more closely mimicking
these features of IPF, since bleomycin-treated mice do
not exhibit basal cell accumulation in the lungs [12]. To
date, only the tracheal epithelium-injury model using
naphtalene reliably increases the proportion of KRT14+
cell populations in the mouse [22]. Interestingly, upon
infection with H1N1, KRT5+p63+ cells also accumulate
in the distal parts of mouse lungs, forming clusters or
pods [14]. In our study, we detected, amongst others,
similar patterns of KRT5+ cells in IPF lungs. Moreover,
regions of pronounced KRT5+ cell metaplasia in IPF
samples were frequently characterized by KRT14 coex-
pression, suggesting hyperplastic potential of the KRT5
+KRT14+ basal cell population. This is consistent with
the hyperproliferative potential attributed to KRT14+
cells. Indeed, the knockdown of KRT14 in basal epithe-
lial cells of the skin leads to cell cycle arrest [25].
In mice, reporter lines have enabled to describe the
different origins of the KRT5+ basal cell population that
arises in the mouse lung after injury. Vaughan et al.
showed that the KRT5+ cells accumulating after H1N1
injury are mostly not of a KRT5+, but a lineage-negative
origin. Another study showed that Clara cells dedifferen-
tiate into p63+KRT5+ basal cells [26]. Interestingly, we
observed a surprising coexpression of KRT5 or KRT14
with the Clara cell marker CC10 in the basal layers of
typical bronchiolar structures in IPF. Therefore, al-
though we cannot provide direct evidence of the origin
of basal cells in IPF, a dedifferentiation of CC10+ cells
cannot be excluded.
The dedifferentiation and transdifferentiation capaci-
ties of basal cells are strongly dependent on the type of
injury [10] and their proximal-to-distal origin [14]. In
the mouse, tracheal KRT5+ cells give rise to club (Clara)
and ciliated cells under steady state or epithelial injury
conditions [6]. After selective ablation of KRT5+KRT6
+p63+ distal airway stem cells (DASC), mice failed to re-
generate AT1+ structures after H1N1 injury [13]. The
differentiation potential of human basal cells is tightly
dependent on their origin and assay-specific environ-
ment [14]. In IPF, Vaughan et al. could not identify
KRT5+SPC+ coexpressing cells. In contrast, in the hu-
man lung, KRT5 was frequently coexpressed with
ProSPC, in particular in hyperplastic regions. Moreover,
further costainings between KRT5 and alveolar/bron-
chial epithelial cell markers suggested a multidirectional
differentiation capacity of these cells in IPF.
The fate of these basal progenitor cells in IPF is likely
to be dependent on the dysregulation of numerous
growth factors and cytokines, which can affect the differ-
entiation potential of basal cells [27], but also on the ad-
jacent ECM [28], all of which is dramatically altered in
IPF. The dysregulated signaling environment changes
the intracellular signaling cascades in the IPF epithelium
[29], in particular with respect to aberrant activation of
developmental pathways in IPF [30, 31]. During lung de-
velopment, SHH, the most broadly expressed Hedgehog
ligand, controls proper branching morphogenesis and
patterns the lung [32]. SHH is upregulated in IPF, where
it localizes to alveolar and bronchiolar epithelial cells, as
previously reported by Bolaños et al. [30]. In agreement,
we observed SHH staining in the distal IPF lung, but not
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Fig. 6 Quantification of total basal cells and KRT5+ and KRT14+ basal
cell subpopulations in the IPF lung. a, b Cells were counted according
to their positivity for p63, KRT5 or KRT14 immunostaining in (a)
conducting airways (1 donor, 2 samples, n = 7 assessed fields/sample)
and (b) in distal regions (5 donors, 1-3 samples/donor, n = 34 assessed
fields in bronchiolized regions (striped bars), n = 24 assessed fields in
fibrotic regions (black bars), n = 11 assessed fields in non fibrotic
regions (white bars)). Data are expressed as mean ± SEM. a A 1-Way
ANOVA revealed a significant interaction (p < 0.0001). The data were
further analyzed for significance with a Dunn’s post-test (**p < versus
“KRT5+”). b A 2-Way ANOVA with Bonferroni post-test revealed a
significant interaction according to the type of remodeled region
(p < 0.0001). Each dataset (bronchiolization, fibrotic, non fibrotic) was
then compared separately with a 1-Way ANOVA test, with a Dunn’s
post-test: ***p < 0.001 versus the neighboring “Bronchiolization”
column, ###p < 0.001 between “Bronchiolization KRT5+” and
“Bronchiolization KRT14+”
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transcription factor GLI1, which is known for its in-
volvement in stem cell renewal in non-small cell lung
cancer [33], localized to the nuclei of most KRT5+ cells
in the distal IPF lung, arguing for activation of the SHH
pathway in these cells. HES1, a transcription factor acti-
vated by canonical Notch signaling, induces Clara cell
differentiation in the developing lung [34]. HES1 is
expressed in KRT5+ cells in areas of honeycombing in
IPF, suggesting impaired differentiation potential into
AT2 cells [12]. Our co-immunostainings for KRT5 and
HES1 confirmed patchy Notch signaling activation in
the KRT5+ subpopulation. In addition, SOX9 partici-
pates in bronchial development. Tight control of SOX9
levels is required for proper epithelial cell proliferation,
since SOX9 inhibits epithelial differentiation in the de-
veloping mouse lung [35]. Upregulation of SOX9 is asso-
ciated with lung cancer [36]. We observed significant
numbers of KRT5+ cells in the IPF lung with prominent
nuclear SOX9+ staining. Altogether, these and other
findings thus suggest abnormal activation of at least
three signaling pathways involved in cell proliferation




































Fig. 7 Costaining of KRT5 and KRT14 with alveolar and bronchial epithelial differentiation markers in the distal IPF lung. Human distal IPF lungs (5
patients) were costained for KRT5 or KRT14 and AQP5 (Alveolar type 1 cell marker), ProSPC (Alveolar type 2 cell marker), acTUB (ciliated cell
marker), CC10 (Clara cell marker) and Mucin 5B (secretory cell marker). One picture with the corresponding high magnification is shown for each
staining. a Left: KRT5 (green) and AQP5 (red). Right: KRT14 (red) and AQP5 (green). b Left: KRT5 (green) and ProSPC (red). Right: KRT14 (red) and
ProSPC (green). c Left: KRT5 (green) and acTUB (red). Right: KRT14 (red) and AQP5 (green). d Left: KRT5 (green) and CC10 (red). Right: KRT14 (red) and
CC10 (green). e Left: KRT5 (green) and MUC5B (red). Right: KRT14 (red) and MUC5B (green). Full bars = 100 μm. Scattered bars = 50 μm
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that the differentiation potential of the KRT5+ popula-
tion in IPF is modified compared with quiescent healthy
cells.
While KRT14+ cells have been reported to coexpress
AT2 cell markers in DAD [18], we could not detect any
costaining of KRT14+ with differentiation markers. The
function of the KRT5+KRT14+ population therefore re-
mains unclear. Under steady-state conditions, both KRT5
+KRT14- and KRT5+KRT14+ subpopulations are mitotic
in the mouse trachea [22]. Interestingly, the increase in
the number of KRT14+ cells and their contribution to the
mitotic pool suggests that this subpopulation gives rise to
a highly mitotic reparative pool after naphtalene injury in
the mouse [22]. The hypothesis of a proliferative function
of KRT14+ cells is reinforced by the tumorigenic potential
demonstrated for KRT14+ cells from the skin [25], but
also in the lung, where tumors spontaneously develop in
knock-in mice for human KRT14 [37]. Yet, some evidence
also suggests a differentiation potential for the KRT5
+KRT14+ population. Indeed, after naphtalene injury,
some KRT14+ cells had a luminal morphology in the
mouse trachea, whereas the differentiating cells were
mostly KRT14-, which indicates a quick shift in the
KRT14 expression during differentiation.
Lately, new pathways determining basal cell fates after
injury have been emerging in the mouse. Pardo-Saganta
et al. showed that depending on the intracellular path-
ways activated in the basal cells, they were committed
either to a ciliated or a secretory cell lineage [38]. These
discoveries, combined with an accurate description of
epithelial progenitor subpopulations in human healthy
and diseased lung, are promising approaches for further
use of lung epithelial progenitor cells for therapeutic
manipulation and epithelial regeneration.
Conclusions
This work provides a quantitative analysis of the regional
distribution of KRT5+KRT14+p63+ and KRT5+KRT14-
p63+ basal cell subpopulations in the healthy human
lung. Dramatic changes in the amount and distribution
of these cell populations are observed in IPF. In IPF,
these populations express differentiated epithelial cell
markers, showing that in a context of injury/disease,
they are likely attempting to regenerate the epithelium.
This work provides a basis for further descriptions of
the molecular pathways that may control the fate of pro-
genitor basal cells in human lung disease.
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Fig. 8 Costaining of KRT5 with developmental pathway markers in
the distal IPF lung. a, b, c, d Sections from IPF human lungs (5
patients) were co-stained for KRT5 (green) and (a) SHH (red), (b) GLI1
(red), (c) SOX9 (red), and (d) HES1 (red), and counterstained with DAPI
(blue). One representative picture, with the corresponding high
magnification panel, is shown for each staining. Full bars = 100 μm.
Scattered bars = 50 μm
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